Search Results
ASH 2013 - Alok Khorana, M.D., discusses the significance of thrombosis in cancer.
Alok Khorana: Rivaroxaban Prevents Cancer-Associated VTE
Rivaroxaban in Cancer-Associated VTE: Results from CALLISTO
Cancer and Thrombosis - Alok A. Khorana, MD
Alok Khorana, MD: Prophylactic Treatment With Rivaroxaban Reduces Cancer Patients' VTE Risk
VTE Prevention in Cancer Patients - Alok A. Khorana, MD
Dr. Alok Khorana - Bio Video
Cancer-Associated Thrombosis | ASH Clinical Practice Guidelines on Venous Thromboembolism
Dr. Khorana Discusses Long-Term Tinzaparin Versus Warfarin in the CATCH Study
Rivaroxaban for thromboprophylaxis in high-risk cancer patients: CASSINI results
Alok A. Khorana: Rivaroxaban Thromboprophylaxis in High-Risk Ambulatory Cancer Patients
ASH Highlights 2016 – Costs Associated with VTE in Cancer Patients Treated with Anticoagulants
